Independent role of C reactive protein to predict major events at one-month and at one-year in acute coronary syndrome without ST elevation;Valor independiente de la proteína C reactiva para predecir acontecimientos mayores al primer mes y al año en los síndromes coronarios agudos sin elevación del ST

Medicina Clinica

Volumn 122, Issue 7, 2004, Pages 248-252

  Bodí, Vicent ^a   Sanchis, Juan ^a   Llàcer, Àngel ^a   Fácila, Lorenzo ^a   Núñez, Julio ^a   Pellicer, Mauricio ^a   Bertomeu, Vicente ^a   Ruiz, Vicente ^a   García, Diego ^a   Chorro, Francisco J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

C reactive protein; Infarction; Prognosis; Troponin; Unstable angina

Indexed keywords

C REACTIVE PROTEIN; TROPONIN;

ADULT; AGED; ARTICLE; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

EID: 11144357173     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13058372     Document Type: Article

References (31)

1. Hamm CW. Cardiac biomarkers for rapid evaluation of chest pain. Circulation 2001;104:1454-6.
2. Sabatine MS, Morrow DA, De Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Simultaneous assessment of troponin I, C-reactive protein and B-type natriuretic peptide. Circulation 2002;105: 1760-3.
3. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001;38:478-85.
4. Gibler WB. Understanding true risk: evaluating troponins in the emergency setting. Am Heart J 1999;137:985-6.
5. Goldmann BU, Christenson RH, Hamm CW, Meinertz T, Ohman EM. Implications of troponin testing in clinical medicine. Curr Control Trials Cardiovasc Med 2001;2:75-84.
6. Ferreiros ER, Boissonnet CP, Pizarro R, Merletti PF, Corrado G, Cagide A, et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 1999;100:1958-63.
7. García-Moll X, Guindo J, Kaski JC. Proteína C reactiva como factor de riesgo coronario. Med Clin (Barc) 2001;117:303-8.
8. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000;343:1139-47.
9. Fernández-Miranda C, Paz M, Aranda JL, Fuertes A, Gómez de la Cámara A. Infección crónica por Chlamydia pneumoniae en pacientes con enfermedad coronaria. Relación con el incremento de los valores de fibrinógeno. Med Clin (Barc) 2002;119:561-4.
10. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 2002;105:1412-5.
11. Bozkurt E, Erol MK, Keles S, Acikel M, Yilmaz M, Gurlertop Y. Relation of plasma homocysteine levels to intracoronary thrombus in instable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol 2002;90:413-5.
12. Schnyder G, Flammer Y, Roffi M, Pin R, Hess OM. Plasma homocysteine levels and late outcome after coronary angioplasty. J Am Coll Cardiol 2002;40:1769-76.
13. De Winter RJ, Fischer J, Bholasingh R, Van Straalen JP, De Jong T, Tijssen JG, et al. C-reactive protein and cardiac troponin T in risk stratification: differences in optimal timing of tests early after the onset of chest pain. Clin Chem 2000; 46:1597-603.
14. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined. A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21:1502-13.
15. Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
16. Lindahl B, Diderholm E, Lagerqvist B, Venge P, Wallentin L. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol 2001;38:979-86.
17. Jurlander B, Farhi ER, Banas JJ Jr, Keany CM, Balu D, Grande P, et al. Coronary angiographic findings and troponin T in patients with unstable angina pectoris. Am J Cardiol 2000;85:810-4.
18. Bodí V, Núñez J, Sanchis J, Llàcer A, Fácila L, Chorro FJ. Utilidad de la troponina I para predecir la disfunción sistólica en los síndromes coronarios agudos. Resultados de un estudio prospectivo y cuantitativo. Rev Esp Cardiol 2003;56:738-41.
19. Newby LK, Storrow AB, Gibler WB, Garvey JL, Tucker JF, Kaplan AL, et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin and troponin I (CHECKMATE) study. Circulation 2001;103:1832-7.
20. Sonel A, Sasseen BM, Fineberg N, Bang N, Wilensky RL. Prospective study correlating fibrinopeptide A, troponin I, myoglobin, and myosin light chain levels with early and late ischemic events in consecutive patients presenting to the emergency department with chest pain. Circulation 2000;102:1107-13.
21. Sanchis J, Bodí V, Llàcer A, Fácila L, Núñez J, Bertomeu V, et al. Usefulness of concomitant myoglobin and troponin elevation as biochemical marker of mortality in non-ST-segment elevation acute coronary syndromes. Am J Cardiol 2003; 91:13-6.
22. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104:365-72.
23. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
24. Bodí V, Fácila L, Sanchis J, Llàcer A, Núñez J, Mainar L, et al. Pronóstico a corto plazo de los pacientes ingresados por probable síndrome coronario agudo sin elevación del segmento ST. Papel de los nuevos marcadores de daño miocárdico y de los reactantes de fase aguda. Rev Esp Cardiol 2002;55:823-30.
25. Bodí V, Núñez J, Sanchis J, Llàcer A, Fácila L, Chorro FJ. Why does C-reactive protein increase in non-ST elevation acute coronary syndromes? Role of myocardial damage. Int J Cardiol 2003; 92:129-35.
26. Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol 2002;39:1917-23.
27. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347:5-12.
28. Schoenhagen P, Tuzcu EM, Ellis SG. Plaque vulnerability, plaque rupture and acute coronary syndromes. Multi-focal manifestation of a systemic disease process. Circulation 2002;106:760-2.
29. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fullfilling prophecy. C-reactive protein attenuates nitric oxide production and inhibit angiogenesis. Circulation 2002;106:r28-r34.
30. Fichtlscherer S, Zeiher AM. Endothelial dysfunction in acute coronary syndromes: association with elevated C-reactive protein levels. Ann Med 2000;32:515-8.
31. James SK, Armstrong P, Barnathan E, Califf R, Lindahl B, Siegbahn A, et al. Troponin and C-reactive protein have different relations to subsequent mortality and myocardial reinfarction after acute coronary syndrome. A GUSTO-IV substudy. J Am Coll Cardiol 2003;41:916-24.